NEWS: Hema Metrics' CRIT-LINE(R) Technology Now Available in the CHF Solutions' Aquadex FlexFlow(TM) Device
Provides
Automatic, Real-Time Feedback On Aquapheresis(TM) Therapy
SALT
LAKE CITY & BROOKLYN PARK, Minn., Jun 30, 2009 (BUSINESS WIRE) -- Hema
Metrics and CHF Solutions jointly announced today that the Hema Metrics
Crit-Line technology is now available in the Aquadex FlexFlow device
manufactured by CHF Solutions, Inc.
The
Aquadex FlexFlow is used to deliver Aquapheresis(TM) therapy, a safe,
predictable, and effective method to remove excess salt and water from patients
with fluid overload. Recently elevated in national treatment guidelines,
Aquapheresis is available in over 250 medical centers and outpatient clinics
worldwide and more than 22,000 patients have received this therapy to date.
The
integrated Crit-Line technology, called CRIT-SAT(TM), allows for the
non-invasive measurement of hematocrit and oxygen saturation during the
Aquapheresis fluid removal process. This additional information provides an early
window on each individual patient's hemodynamic response and helps ensure the
most appropriate fluid removal is achieved.
"Hematocrit
monitoring with Aquapheresis provides enhanced peace-of-mind and further
empowers healthcare professionals in their continuing efforts to achieve the
guideline-directed treatment goal of euvolemia in fluid overloaded
patients," said Dave Springer, President and CEO of CHF Solutions.
"Hema
Metrics is pleased to have joined forces with CHF Solutions," said Patrick
Moriarty, President and CEO of Hema Metrics. "We have always believed the
Crit-Line technology could be very useful in the treatment of patients with
fluid overload. Having the Crit-Line technology more readily available in the
hospital setting will open more markets for Hema Metrics."
About
Hema Metrics LLC
Hema
Metrics LLC provides diagnostic products for the hemodialysis market. Hema
Metrics manufactures, markets and distributes the "CRIT-LINE(R)"
system. The monitoring and diagnostic capability of the CRIT-LINE(R) technology
provides better clinical outcomes and lower overall costs and improved quality
of life for dialysis patients. For more information, visit www.hemametrics.com
About
CHF Solutions, Inc.
CHF
Solutions, based in Brooklyn Park, Minn., is a privately held manufacturer of
medical devices for cardiac care. The company's mission is to provide medical
practitioners with innovative and practical solutions that enable the treatment
of patients with unmet clinical needs. For more information, go to www.chfsolutions.com
SOURCE:
CHF Solutions Inc.
Hema Metrics LLC Patrick Moriarty, 801-451-9000 Ext. 103 President/CEO pmoriarty@hemametrics.com or CHF Solutions Inc. Dave Springer, 763-463-4600 President/CEO dspringer@chfsolutions.com Copyright
Business Wire 2009
<< Home